2,890 hedge funds and large institutions have $106B invested in Pfizer in 2024 Q3 according to their latest regulatory filings, with 190 funds opening new positions, 1,236 increasing their positions, 1,189 reducing their positions, and 126 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more funds holding

Funds holding:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

1% more capital invested

Capital invested by funds: $105B → $106B (+$1.23B)

1.2% less ownership

Funds ownership: 65.92%64.72% (-1.2%)

38% less call options, than puts

Call options by funds: $2.51B | Put options by funds: $4.05B

Holders
2,890
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
40
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.51B
Puts
$4.05B
Net Calls
Net Calls Change

Top Buyers

1 +$421M
2 +$372M
3 +$343M
4
BlackRock
BlackRock
New York
+$336M
5
Deutsche Bank
Deutsche Bank
Germany
+$284M

Top Sellers

1 -$997M
2 -$357M
3 -$263M
4
Franklin Resources
Franklin Resources
California
-$261M
5
DCP
D1 Capital Partners
New York
-$213M
Name Holding Trade Value Shares
Change
Change in
Stake
1901
$540K
1902
$540K
1903
$538K
1904
$537K
1905
$537K
1906
$537K
1907
$536K
1908
$535K
1909
$535K
1910
$535K
1911
$533K
1912
$533K
1913
$533K
1914
$533K
1915
$532K
1916
$531K
1917
$531K
1918
$530K
1919
$526K
1920
$526K
1921
$526K
1922
$524K
1923
$524K
1924
$523K
1925
$523K